About: Transfusion Risks and Transfusion-related Pro-inflammatory Responses

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Transfusion Risks and Transfusion-related Pro-inflammatory Responses Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Transfusion Risks and Transfusion-related Pro-inflammatory Responses
Creator	Zhang, Lini Despotis, George Lublin, Douglas
Source	Elsevier; Medline; PMC
abstract	Despite improvements in blood screening and administration techniques, serious adverse events related to transfusion continue to occur, albeit at a much lower incidence. In addition to the development and implementation of new screening and blood purification/modification techniques and implementation of an optimal blood management program, the incidence and consequences of transfusion reactions can be reduced by a basic understanding of transfusion-related complications. Although acute hemolytic transfusion reactions, transfusion-associated anaphylaxis and sepsis, and transfusion-associated acute lung injury occur infrequently, diligence in administration of blood and monitoring for development of respective signs/symptoms can minimize the severity of these potentially life-threatening complications. In addition, emerging blood-banking techniques such as psoralen-UV inactivation of pathogens and use of patient identification systems may attenuate the incidence of adverse events related to transfusion. With respect to optimizing blood management by means of an effective blood management program involving pharmacologic and nonpharmacologic strategies, the ability to reduce use of blood products and to decrease operative time or re-exploration rates has important implications for disease prevention, blood inventory and costs, and overall health care costs.
has issue date	2007-02-28(xsd:dateTime)
bibo:doi	10.1016/j.hoc.2006.11.002
bibo:pmid	17258124
has license	els-covid
sha1sum (hex)	e4a079428993a79ee89b9f6dda1d433cf63bc299
schema:url	https://doi.org/10.1016/j.hoc.2006.11.002
resource representing a document's title	Transfusion Risks and Transfusion-related Pro-inflammatory Responses
has PubMed Central identifier	PMC7135740
has PubMed identifier	17258124
schema:publication	Hematology/Oncology Clinics of North America
resource representing a document's body	covid:e4a079428993a79ee89b9f6dda1d433cf63bc299#body_text
is schema:about of	named entity 'Administration' named entity 'lead' named entity 'mortality' named entity 'hemolytic transfusion reactions' named entity 'TRALI' named entity 'Responses' named entity 'DISEASE TRANSMISSION' named entity 'MORTALITY RATE' named entity 'UNITS' named entity 'UNITED STATES' named entity 'TRALI' named entity 'PLATELET TRANSFUSIONS' named entity 'CAUSES OF DEATH' named entity 'SERIOUS ADVERSE EVENTS' named entity 'INCIDENCE' named entity 'MORTALITY' named entity 'TRANSFUSIONS' named entity 'LEAD' named entity 'PLATELETS' named entity '50%' named entity 'SHORT-TERM' named entity '1.2' named entity 'SINGLE' named entity 'FOOD AND DRUG ADMINISTRATION' named entity 'INCLUDING' named entity 'BASED' named entity 'HEMATOLOGY' named entity 'PROBABLY' named entity 'PROJECTIONS' named entity 'RANDOM' named entity 'ASSOCIATED' named entity 'DEATHS' named entity 'EARLY' named entity '300' named entity 'FATALITIES' named entity '100%' named entity 'DEATH' named entity 'ABO BLOOD GROUP' named entity '220' named entity 'CLINICS' named entity 'POOLS' named entity 'TRANSFUSION-RELATED ACUTE LUNG INJURY' named entity 'OCCUR' named entity '40%' named entity 'RISKS' named entity 'ESTIMATED' named entity 'RED CELL' named entity 'TOTAL' named entity 'ADMINISTERED' named entity 'SYNDROME' named entity 'HEMOLYTIC TRANSFUSION REACTIONS' named entity 'LESS THAN' named entity '3A5' named entity 'ANNUALLY' named entity 'ADVERSE EVENTS' named entity 'REPORTS' named entity '5B1' named entity 'RECENT' covid:arg/e4a079428993a79ee89b9f6dda1d433cf63bc299 named entity '130' named entity 'LONG-TERM' named entity 'MILLION' named entity 'APPROXIMATELY' named entity '10%' named entity 'APHERESIS' named entity 'REPORTED' named entity '1.6' named entity 'ACCOUNT' named entity 'TRANSFUSION' named entity 'TRANSFUSION' named entity 'NORTH AMERICA' named entity 'RELATED' named entity 'SUGGEST' named entity '0.5' named entity 'REST' named entity 'PATIENTS' named entity 'HAVE' named entity 'INDICATED' named entity 'PLATELET'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software